Zobrazeno 1 - 10
of 354
pro vyhledávání: '"E. Vivas"'
Autor:
José Roberto Estupiñan‐Jiménez, Valeria Villarreal‐García, Vianey Gonzalez‐Villasana, Pablo E. Vivas‐Mejia, Jose Manuel Vazquez‐Guillen, Patricio Adrián Zapata‐Morin, Marienid Flores‐Colón, Claudia Altamirano‐Torres, Ezequiel Viveros‐Valdez, Cristina Ivan, Mohammed H. Rashed, Recep Bayraktar, Cristina Rodríguez‐Padilla, Gabriel Lopez‐Berestein, Diana Resendez‐Perez
Publikováno v:
Thoracic Cancer, Vol 15, Iss 32, Pp 2298-2308 (2024)
Abstract Background Despite advances in screening and therapy, breast cancer (BC) remains the predominant cancer in women globally. Dysregulation of microRNAs (miRNAs) is pivotal in carcinogenesis across various cancers, including BC. Evidence indica
Externí odkaz:
https://doaj.org/article/a1b3346bdbed4eaaa2d23f4f940cb712
Autor:
Betzaida Castillo Cruz, Sandra Chinapen Barletta, Bryan G. Ortiz Muñoz, Adriana S. Benitez-Reyes, Omar A. Amalbert Perez, Alexander C. Cardona Amador, Pablo E. Vivas-Mejia, Gabriel L. Barletta
Publikováno v:
Pharmaceuticals, Vol 17, Iss 10, p 1344 (2024)
Background: Encapsulation of siRNA fragments inside liposome vesicles has emerged as an effective method for delivering siRNAs in vitro and in vivo. However, the liposome’s fluid-phospholipid bilayer of liposomes allows siRNA fragments to diffuse o
Externí odkaz:
https://doaj.org/article/d8e8f52e1e90405d9c6b309b2cd9736f
Autor:
Luis E. Velázquez-Vega, Michael Rivera-Robles, Annelis O. Sánchez-Álvarez, Pablo E. Vivas-Mejía, Miciely Aponte-Reyes, Ailed M. Cruz-Collazo, Nilmary Grafals-Ruiz, Stephanie Dorta-Estremera, Eliud Hernández-O'Farrill, Cornelis P Vlaar, Suranganie Dharmawardhane
Publikováno v:
Translational Oncology, Vol 44, Iss , Pp 101928- (2024)
Trastuzumab and trastuzumab-based treatments are the standard of care for breast cancer patients who overexpress the human epidermal growth factor receptor 2 (HER2). However, patients often develop resistance to trastuzumab via signaling from alterna
Externí odkaz:
https://doaj.org/article/08593e49e06c4c999cc8684c83fb0cd2
Publikováno v:
Journal of Clinical and Translational Science, Vol 8, Pp 26-26 (2024)
OBJECTIVES/GOALS: This project focuses on investigating the potential of Simalikalactone D (SKD) as an anticancer agent, exploring the mechanisms underlying SKD’s induction of cell death, and assessing the impact of SKD on diverse breast cancer cel
Externí odkaz:
https://doaj.org/article/4f76c2223a14459c84c9f4538c391489
Autor:
Nilmary Grafals-Ruiz, Annelis O. Sánchez-Álvarez, Yasmarie Santana-Rivera, Eunice L. Lozada-Delgado, Robert J. Rabelo-Fernandez, Christian I. Rios-Vicil, Fatima Valiyeva, Pablo E. Vivas-Mejia
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionGlioblastoma (GBM) is a highly aggressive and lethal primary brain tumor. Despite limited treatment options, the overall survival of GBM patients has shown minimal improvement over the past two decades. Factors such as delayed cancer diag
Externí odkaz:
https://doaj.org/article/729159b29ebf449a8320808f42799637
Autor:
Betzaida Castillo Cruz, Marienid Flores Colón, Robert J. Rabelo Fernandez, Pablo E. Vivas-Mejia, Gabriel L. Barletta
Publikováno v:
ACS Omega, Vol 7, Iss 4, Pp 3731-3737 (2022)
Externí odkaz:
https://doaj.org/article/57cdd35469424d47a23ed4ae224ef9dc
Autor:
Grzegorz Chojnowski, Adam J. Simpkin, Diego A. Leonardo, Wolfram Seifert-Davila, Dan E. Vivas-Ruiz, Ronan M. Keegan, Daniel J. Rigden
Publikováno v:
IUCrJ, Vol 9, Iss 1, Pp 86-97 (2022)
Although experimental protein-structure determination usually targets known proteins, chains of unknown sequence are often encountered. They can be purified from natural sources, appear as an unexpected fragment of a well characterized protein or app
Externí odkaz:
https://doaj.org/article/c1c2d178143c4afebef407a453f3cfb8
Autor:
Valeria Villarreal-García, José Roberto Estupiñan-Jiménez, Pablo E. Vivas-Mejía, Vianey Gonzalez-Villasana, José Manuel Vázquez-Guillén, Diana Reséndez-Pérez
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Breast cancer (BC) is the most common cancer in women worldwide. This highly heterogeneous disease is molecularly stratified into luminal A, luminal B, HER2, triple-negative/basal-like, and normal-like subtypes. An important aspect in BC progression
Externí odkaz:
https://doaj.org/article/4e62908643124976bd98834fb509f947
An Emergent Role for Mitochondrial Bioenergetics in the Action of Snake Venom Toxins on Cancer Cells
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Beyond the role of mitochondria in apoptosis initiation/execution, some mitochondrial adaptations support the metastasis and chemoresistance of cancer cells. This highlights mitochondria as a promising target for new anticancer strategies. Emergent e
Externí odkaz:
https://doaj.org/article/6dba963cdccf4777ae15048caf9d8cfc
Autor:
Dan E. Vivas-Ruiz, Paola Rosas, Alex Proleón, Daniel Torrejón, Fanny Lazo, Ana Belén Tenorio-Ricca, Francisco Guajardo, Cristopher Almarza, Víctor Andrades, Jessica Astorga, Daniel Oropesa, Jorge Toledo, María Jesús Vera, Jorge Martínez, Ramiro Araya-Maturana, Karen Dubois-Camacho, Marcela A. Hermoso, Valéria G. Alvarenga, Eladio Flores Sanchez, Armando Yarlequé, Luciana Souza Oliveira, Félix A. Urra
Publikováno v:
Pharmaceutics, Vol 15, Iss 5, p 1533 (2023)
From the venom of the Bothrops pictus snake, an endemic species from Peru, we recently have described toxins that inhibited platelet aggregation and cancer cell migration. In this work, we characterize a novel P-III class snake venom metalloproteinas
Externí odkaz:
https://doaj.org/article/43eed5d3f77f43fea778f614b04bc86b